Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71051 - 71075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	HSPA6	3310	upregulated	Silicon Dioxide analog results in increased expression of HSPA6 mRNA	1q23.3	A24194 A24195
Silicon dioxide	Approved	HSPA6	3310	upregulated	Silicon Dioxide results in increased expression of HSPA6 mRNA	1q23.3	A24197 A24196
Silicon dioxide	Approved	HSPB8	26353	upregulated	Silicon Dioxide analog results in increased expression of HSPB8 mRNA	12q24.23	A24195
Silicon dioxide	Approved	HSPB8	26353	upregulated	Silicon Dioxide results in increased expression of HSPB8 mRNA	12q24.23	A24196
Silicon dioxide	Approved	HSPB9	94086	downregulated	Silicon Dioxide analog results in decreased expression of HSPB9 mRNA	17q21.2	A24195
Silicon dioxide	Approved	HSPBAP1	79663	upregulated	Silicon Dioxide analog results in increased expression of HSPBAP1 mRNA	3q21.1	A24195
Silicon dioxide	Approved	HSPH1	10808	upregulated	Silicon Dioxide results in increased expression of HSPH1 mRNA	13q12.3	A24196
Silicon dioxide	Approved	HTATIP2	10553	downregulated	Silicon Dioxide analog results in decreased expression of HTATIP2 mRNA	11p15.1	A24195
Silicon dioxide	Approved	HTATIP2	10553	upregulated	Silicon Dioxide results in increased expression of HTATIP2 mRNA	11p15.1	A24196
Silicon dioxide	Approved	HTR3D	200909	downregulated	Silicon Dioxide analog results in decreased expression of HTR3D mRNA	3q27.1	A24195
Silicon dioxide	Approved	HTR4	3360	downregulated	Silicon Dioxide analog results in decreased expression of HTR4 mRNA	5q32	A24194
Silicon dioxide	Approved	HTR7	3363	upregulated	Silicon Dioxide analog results in increased expression of HTR7 mRNA	10q23.31	A24195
Silicon dioxide	Approved	HTR7P1	93164	upregulated	Silicon Dioxide analog results in increased expression of HTR7P1 mRNA	12p13.1	A24195
Silicon dioxide	Approved	HTRA1	5654	downregulated	Silicon Dioxide analog results in decreased expression of HTRA1 mRNA	10q26.13	A24195
Silicon dioxide	Approved	HTRA3	94031	downregulated	Silicon Dioxide analog results in decreased expression of HTRA3 mRNA	4p16.1	A24195
Silicon dioxide	Approved	HUS1B	135458	upregulated	Silicon Dioxide analog results in increased expression of HUS1B mRNA	6p25.3	A24195
Silicon dioxide	Approved	HYAL1	3373	downregulated	Silicon Dioxide analog results in decreased expression of HYAL1 mRNA	3p21.31	A24195
Silicon dioxide	Approved	HYI	81888	upregulated	Silicon Dioxide analog results in increased expression of HYI mRNA	1p34.2	A24195
Silicon dioxide	Approved	ICAM1	3383	upregulated	Silicon Dioxide analog results in increased expression of ICAM1 mRNA	19p13.2	A24194 A24195
Silicon dioxide	Approved	ICAM1	3383	upregulated	Silicon Dioxide results in increased expression of ICAM1 mRNA	19p13.2	A24200 A24196
Silicon dioxide	Approved	ICAM4	3386	upregulated	Silicon Dioxide analog results in increased expression of ICAM4 mRNA	19p13.2	A24194
Silicon dioxide	Approved	ICAM5	7087	upregulated	Silicon Dioxide analog results in increased expression of ICAM5 mRNA	19p13.2	A24194
Silicon dioxide	Approved	ICE2	79664	downregulated	Silicon Dioxide results in decreased expression of ICE2 mRNA	15q22.2	A24196
Silicon dioxide	Approved	ICK	22858	downregulated	Silicon Dioxide analog results in decreased expression of ICK mRNA	6p12.1	A24195
Silicon dioxide	Approved	ICK	22858	downregulated	Silicon Dioxide results in decreased expression of ICK mRNA	6p12.1	A24196

Displaying entries 71051 - 71075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability